Literature DB >> 11136999

Possible extrapyramidal system degradation in Parkinson's disease.

M Drobný1, E Kurca.   

Abstract

Extrapyramidal system, a rich network of nerve and glial cells consists of subcortical and cortical grey matter. The system serves as an integrator of unaware, automatic, repeated, spontaneous, complicated and purposeful motor samples. Muscle tone regulation and its distribution is another decisive extrapyramidal function. This review article concerns to some degradation mechanisms in extrapyramidal system, as either the programmed cell death or apoptosis. The physiologic extracellular decreasing signals creating apoptosis (nerve growth factor--fall) are either genetically expressed or there are neuropathophysiologic processes that may activate pathways leading to apoptosis, namely oxidative stress, glutamate toxicity and calcium homeostasis disruption. The level of dopamine transporter expression (mRNA, methyl-phenyl-pyridinium) might determine the vulnerability of the nigral neurons to the Parkinsonian insult. The most common clinical picture of extrapyramidal disorder-Parkinson's disease-consists of an active dopamine cell death-apoptosis, which is partially programmed like as programmed cell death and partially accidentally installed chain of events. Without morphological criteria, biochemical indicators such as laddered DNA fragmentation pattern and/or the requirement for macromolecular synthesis merely suggest but do not provide unequivocal evidence for apoptosis. There are either genetic or acquired conditions creating unbalance of Bax/Bcl-2 families-proapoptotic and prooncogenic factors, respectively. The first Bax gene cooperates with other genes coding the new transmembrane proteins into the mitochondrial megapores determinating transition by means of death receptors. Bcl-2 codes prooncogenic mitoses and tissue proliferation. The neuroprotective hypothesis of the dopamine agonist action is a very attractive working hypothesis and some of its tenets are derived from the oxidative stress hypothesis for neurodegeneration, but this hypothesis is still controversial.

Entities:  

Mesh:

Year:  2000        PMID: 11136999     DOI: 10.1016/s0361-9230(00)00367-1

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  4 in total

1.  Pain in Parkinson's Disease: A Cross-Sectional Study of Its Prevalence, Types, and Relationship to Depression and Quality of Life.

Authors:  Peter Valkovic; Michal Minar; Helena Singliarova; Jan Harsany; Marta Hanakova; Jana Martinkova; Jan Benetin
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

2.  Epoxyeicosatrienoic Acid Inhibits the Apoptosis of Cerebral Microvascular Smooth Muscle Cells by Oxygen Glucose Deprivation via Targeting the JNK/c-Jun and mTOR Signaling Pathways.

Authors:  Youyang Qu; Yu Liu; Yanmei Zhu; Li Chen; Wei Sun; Yulan Zhu
Journal:  Mol Cells       Date:  2017-10-27       Impact factor: 5.034

Review 3.  Clinical aspects of adherence to pharmacotherapy in Parkinson disease: A PRISMA-compliant systematic review.

Authors:  Igor Straka; Michal Minár; Andrea Gažová; Peter Valkovič; Ján Kyselovič
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

4.  Nonmotor symptoms in early- and advanced-stage Parkinson's disease patients on dopaminergic therapy: how do they correlate with quality of life?

Authors:  Peter Valkovic; Jan Harsany; Marta Hanakova; Jana Martinkova; Jan Benetin
Journal:  ISRN Neurol       Date:  2014-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.